CN Stock MarketDetailed Quotes

Jiangxi Fushine Pharmaceutical (300497)

Watchlist
  • 16.93
  • +0.67+4.12%
Market Closed May 15 15:00 CST
9.12BMarket Cap2418.57P/E (TTM)

Jiangxi Fushine Pharmaceutical (300497) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q9)Sep 30, 2025
(Q6)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
Total operating revenue
53.09%357.76M
0.61%1.18B
-21.24%769.35M
-24.58%514.67M
-31.35%233.7M
-26.83%1.18B
-24.06%976.88M
-20.25%682.41M
-14.45%340.43M
-2.28%1.61B
Operating revenue
53.09%357.76M
0.61%1.18B
-21.24%769.35M
-24.58%514.67M
-31.35%233.7M
-26.83%1.18B
-24.06%976.88M
-20.25%682.41M
-14.45%340.43M
-2.28%1.61B
Other operating revenue
----
-30.36%3.4M
----
-40.85%1.6M
----
-60.60%4.88M
----
-73.72%2.71M
----
-13.19%12.39M
Total operating cost
15.13%291.94M
-5.75%1.26B
-19.97%862.33M
-25.00%551.33M
-27.13%253.59M
-24.62%1.34B
-21.03%1.08B
-19.63%735.16M
-19.35%347.98M
9.24%1.77B
Operating cost
11.27%220.7M
-7.25%986.85M
-23.11%676.66M
-29.69%429.9M
-31.35%198.35M
-26.04%1.06B
-22.92%880.03M
-20.87%611.47M
-18.89%288.91M
6.55%1.44B
Operating tax surcharges
20.68%4.82M
-1.92%16.34M
-6.04%11.86M
-3.44%8.28M
-16.50%3.99M
0.00%16.66M
10.26%12.63M
28.27%8.57M
44.28%4.78M
9.33%16.66M
Operating expense
45.74%3.25M
17.39%19.7M
-22.94%9.74M
-21.83%6.17M
-5.24%2.23M
-52.50%16.79M
-56.66%12.65M
-59.73%7.9M
-73.79%2.36M
3.30%35.34M
Administration expense
28.20%32.85M
-3.95%133.33M
-1.70%93.05M
-0.60%59.64M
-12.64%25.62M
-13.42%138.8M
-8.01%94.66M
-12.80%60M
-10.10%29.33M
8.85%160.32M
Financial expense
85.84%17.35M
68.95%44.83M
18.59%26.91M
39.45%17.43M
38.75%9.34M
2.50%26.53M
44.63%22.69M
71.98%12.5M
-38.09%6.73M
12,304.42%25.88M
-Interest expense (Financial expense)
17.31%12.22M
13.94%46.24M
-2.38%29.86M
-2.50%20.22M
-3.60%10.42M
-3.46%40.58M
-3.00%30.59M
-0.16%20.74M
5.69%10.81M
2.27%42.03M
-Interest Income (Financial expense)
45.93%-764.06K
17.51%-5.51M
17.61%-4.51M
22.12%-3.18M
39.59%-1.41M
28.16%-6.68M
19.52%-5.47M
11.37%-4.08M
5.34%-2.34M
60.10%-9.29M
Research and development
-7.67%12.98M
-20.30%59.5M
-19.64%44.1M
-13.84%29.92M
-11.45%14.06M
-23.39%74.66M
-13.58%54.88M
-12.39%34.73M
-18.50%15.87M
25.83%97.45M
Credit Impairment Loss
-199.39%-5.03M
-166.17%-1.83M
308.17%2.59M
263.85%3.41M
1,239.37%5.06M
84.31%-685.72K
79.98%-1.24M
49.87%-2.08M
41.28%-443.85K
-24.68%-4.37M
Asset Impairment Loss
52.33%-3.39M
92.77%-11.33M
-306.81%-3.11M
173.00%557.83K
---7.12M
-202.76%-156.72M
58.75%-764.17K
77.32%-764.17K
----
39.69%-51.76M
Other net revenue
-121.00%-5.68M
109.37%11.94M
-16.32%31.65M
7.41%33.7M
132.00%27.04M
-96.75%-127.48M
570.30%37.83M
456.17%31.38M
4,839.37%11.65M
58.76%-64.79M
Fair value change income
---406.12K
-427.14%-1.27M
----
----
----
-136.67%-241.79K
----
----
----
100.83%659.37K
Invest income
----
8.70%-12.55M
12.89%-942.03K
1.14%-1.11M
-54.42%50.44K
14.96%-13.74M
75.16%-1.08M
62.69%-1.13M
-83.38%110.65K
-338.96%-16.16M
-Including: Investment income associates
----
7.21%-13.72M
0.67%-1.96M
0.67%-1.96M
----
-3.88%-14.79M
20.41%-1.97M
20.41%-1.97M
----
-344.60%-14.23M
Asset deal income
----
-264.28%-377.06K
36.05%-66.93K
112.97%13.58K
----
-235.67%-103.51K
-1,376.38%-104.67K
-1,376.38%-104.67K
----
-81.32%76.3K
Other revenue
-89.16%3.15M
-10.73%39.29M
-19.10%33.18M
-13.03%30.83M
142.36%29.05M
550.42%44.02M
818.05%41.02M
868.77%35.45M
1,043.28%11.99M
-54.16%6.77M
Operating profit
741.46%60.14M
77.84%-63.61M
2.40%-61.32M
86.15%-2.96M
74.23%7.15M
-25.15%-287.07M
27.00%-62.83M
68.52%-21.37M
112.14%4.1M
-71.24%-229.39M
Add:Non operating Income
-94.59%38.2K
99.47%1.64M
259.60%1.38M
311.55%1.13M
815.83%706.42K
-10.73%820.07K
-50.07%383.57K
-48.89%274.75K
-74.87%77.13K
64.43%918.63K
Less:Non operating expense
596.15%983.86K
39.73%3.23M
135.19%1.7M
130.89%987.02K
-59.72%141.33K
-50.81%2.31M
-49.30%723.06K
-22.46%427.48K
317.08%350.9K
-49.52%4.7M
Total profit
667.54%59.2M
77.40%-65.21M
2.41%-61.65M
86.91%-2.82M
101.45%7.71M
-23.76%-288.56M
27.16%-63.17M
68.30%-21.52M
111.40%3.83M
-63.39%-233.17M
Less:Income tax cost
-103.70%-263.12K
72.41%-2.24M
0.03%6.04M
30.46%7.18M
55.48%7.1M
18.18%-8.11M
-2.37%6.04M
14,999.86%5.5M
40,276.92%4.57M
-146.19%-9.91M
Net profit
9,658.53%59.46M
77.55%-62.97M
2.20%-67.68M
63.02%-9.99M
182.35%609.29K
-25.62%-280.45M
25.51%-69.21M
60.22%-27.02M
97.80%-739.91K
-35.99%-223.26M
Net profit from continuing operation
9,658.53%59.46M
77.55%-62.97M
2.20%-67.68M
63.02%-9.99M
182.35%609.29K
-25.62%-280.45M
---69.21M
60.22%-27.02M
97.80%-739.91K
-35.99%-223.26M
Less:Minority Profit
-6.62%-1.74M
4.86%-7.94M
30.83%-4.93M
32.48%-3.08M
26.21%-1.63M
62.81%-8.35M
36.72%-7.13M
44.77%-4.56M
35.88%-2.21M
1.09%-22.46M
Net profit of parent company owners
2,633.39%61.2M
79.78%-55.03M
-1.09%-62.75M
69.23%-6.91M
52.46%2.24M
-35.51%-272.1M
23.96%-62.07M
62.36%-22.46M
104.87%1.47M
-41.94%-200.8M
Earning per share
Basic earning per share
2,750.00%0.114
80.39%-0.1
0.00%-0.12
75.00%-0.01
33.33%0.004
-37.84%-0.51
20.00%-0.12
63.64%-0.04
105.36%0.003
-42.31%-0.37
Diluted earning per share
2,750.00%0.114
80.39%-0.1
0.00%-0.12
75.00%-0.01
33.33%0.004
-37.84%-0.51
20.00%-0.12
63.64%-0.04
105.36%0.003
-42.31%-0.37
Other composite income
-99.44K
2,612.56%27.44M
138.43%1.01M
-124.40%-2.63M
Other composite income of parent company owners
---50.71K
2,612.56%27.44M
----
----
----
138.43%1.01M
----
----
----
-124.40%-2.63M
Other composite income of minority owners
---48.72K
----
----
----
----
----
----
----
----
----
Total composite income
9,642.21%59.36M
87.28%-35.53M
2.20%-67.68M
63.02%-9.99M
182.35%609.29K
-23.71%-279.44M
25.51%-69.21M
60.22%-27.02M
97.80%-739.91K
-47.27%-225.89M
Total composite income of parent company owners
2,631.13%61.14M
89.82%-27.59M
-1.09%-62.75M
69.23%-6.91M
52.46%2.24M
-33.26%-271.09M
23.96%-62.07M
62.36%-22.46M
104.87%1.47M
-55.67%-203.43M
Total composite income of minority owners
-9.61%-1.79M
4.86%-7.94M
30.83%-4.93M
32.48%-3.08M
26.21%-1.63M
62.81%-8.35M
36.72%-7.13M
44.77%-4.56M
35.88%-2.21M
1.09%-22.46M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q9)Sep 30, 2025(Q6)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023
Total operating revenue 53.09%357.76M0.61%1.18B-21.24%769.35M-24.58%514.67M-31.35%233.7M-26.83%1.18B-24.06%976.88M-20.25%682.41M-14.45%340.43M-2.28%1.61B
Operating revenue 53.09%357.76M0.61%1.18B-21.24%769.35M-24.58%514.67M-31.35%233.7M-26.83%1.18B-24.06%976.88M-20.25%682.41M-14.45%340.43M-2.28%1.61B
Other operating revenue -----30.36%3.4M-----40.85%1.6M-----60.60%4.88M-----73.72%2.71M-----13.19%12.39M
Total operating cost 15.13%291.94M-5.75%1.26B-19.97%862.33M-25.00%551.33M-27.13%253.59M-24.62%1.34B-21.03%1.08B-19.63%735.16M-19.35%347.98M9.24%1.77B
Operating cost 11.27%220.7M-7.25%986.85M-23.11%676.66M-29.69%429.9M-31.35%198.35M-26.04%1.06B-22.92%880.03M-20.87%611.47M-18.89%288.91M6.55%1.44B
Operating tax surcharges 20.68%4.82M-1.92%16.34M-6.04%11.86M-3.44%8.28M-16.50%3.99M0.00%16.66M10.26%12.63M28.27%8.57M44.28%4.78M9.33%16.66M
Operating expense 45.74%3.25M17.39%19.7M-22.94%9.74M-21.83%6.17M-5.24%2.23M-52.50%16.79M-56.66%12.65M-59.73%7.9M-73.79%2.36M3.30%35.34M
Administration expense 28.20%32.85M-3.95%133.33M-1.70%93.05M-0.60%59.64M-12.64%25.62M-13.42%138.8M-8.01%94.66M-12.80%60M-10.10%29.33M8.85%160.32M
Financial expense 85.84%17.35M68.95%44.83M18.59%26.91M39.45%17.43M38.75%9.34M2.50%26.53M44.63%22.69M71.98%12.5M-38.09%6.73M12,304.42%25.88M
-Interest expense (Financial expense) 17.31%12.22M13.94%46.24M-2.38%29.86M-2.50%20.22M-3.60%10.42M-3.46%40.58M-3.00%30.59M-0.16%20.74M5.69%10.81M2.27%42.03M
-Interest Income (Financial expense) 45.93%-764.06K17.51%-5.51M17.61%-4.51M22.12%-3.18M39.59%-1.41M28.16%-6.68M19.52%-5.47M11.37%-4.08M5.34%-2.34M60.10%-9.29M
Research and development -7.67%12.98M-20.30%59.5M-19.64%44.1M-13.84%29.92M-11.45%14.06M-23.39%74.66M-13.58%54.88M-12.39%34.73M-18.50%15.87M25.83%97.45M
Credit Impairment Loss -199.39%-5.03M-166.17%-1.83M308.17%2.59M263.85%3.41M1,239.37%5.06M84.31%-685.72K79.98%-1.24M49.87%-2.08M41.28%-443.85K-24.68%-4.37M
Asset Impairment Loss 52.33%-3.39M92.77%-11.33M-306.81%-3.11M173.00%557.83K---7.12M-202.76%-156.72M58.75%-764.17K77.32%-764.17K----39.69%-51.76M
Other net revenue -121.00%-5.68M109.37%11.94M-16.32%31.65M7.41%33.7M132.00%27.04M-96.75%-127.48M570.30%37.83M456.17%31.38M4,839.37%11.65M58.76%-64.79M
Fair value change income ---406.12K-427.14%-1.27M-------------136.67%-241.79K------------100.83%659.37K
Invest income ----8.70%-12.55M12.89%-942.03K1.14%-1.11M-54.42%50.44K14.96%-13.74M75.16%-1.08M62.69%-1.13M-83.38%110.65K-338.96%-16.16M
-Including: Investment income associates ----7.21%-13.72M0.67%-1.96M0.67%-1.96M-----3.88%-14.79M20.41%-1.97M20.41%-1.97M-----344.60%-14.23M
Asset deal income -----264.28%-377.06K36.05%-66.93K112.97%13.58K-----235.67%-103.51K-1,376.38%-104.67K-1,376.38%-104.67K-----81.32%76.3K
Other revenue -89.16%3.15M-10.73%39.29M-19.10%33.18M-13.03%30.83M142.36%29.05M550.42%44.02M818.05%41.02M868.77%35.45M1,043.28%11.99M-54.16%6.77M
Operating profit 741.46%60.14M77.84%-63.61M2.40%-61.32M86.15%-2.96M74.23%7.15M-25.15%-287.07M27.00%-62.83M68.52%-21.37M112.14%4.1M-71.24%-229.39M
Add:Non operating Income -94.59%38.2K99.47%1.64M259.60%1.38M311.55%1.13M815.83%706.42K-10.73%820.07K-50.07%383.57K-48.89%274.75K-74.87%77.13K64.43%918.63K
Less:Non operating expense 596.15%983.86K39.73%3.23M135.19%1.7M130.89%987.02K-59.72%141.33K-50.81%2.31M-49.30%723.06K-22.46%427.48K317.08%350.9K-49.52%4.7M
Total profit 667.54%59.2M77.40%-65.21M2.41%-61.65M86.91%-2.82M101.45%7.71M-23.76%-288.56M27.16%-63.17M68.30%-21.52M111.40%3.83M-63.39%-233.17M
Less:Income tax cost -103.70%-263.12K72.41%-2.24M0.03%6.04M30.46%7.18M55.48%7.1M18.18%-8.11M-2.37%6.04M14,999.86%5.5M40,276.92%4.57M-146.19%-9.91M
Net profit 9,658.53%59.46M77.55%-62.97M2.20%-67.68M63.02%-9.99M182.35%609.29K-25.62%-280.45M25.51%-69.21M60.22%-27.02M97.80%-739.91K-35.99%-223.26M
Net profit from continuing operation 9,658.53%59.46M77.55%-62.97M2.20%-67.68M63.02%-9.99M182.35%609.29K-25.62%-280.45M---69.21M60.22%-27.02M97.80%-739.91K-35.99%-223.26M
Less:Minority Profit -6.62%-1.74M4.86%-7.94M30.83%-4.93M32.48%-3.08M26.21%-1.63M62.81%-8.35M36.72%-7.13M44.77%-4.56M35.88%-2.21M1.09%-22.46M
Net profit of parent company owners 2,633.39%61.2M79.78%-55.03M-1.09%-62.75M69.23%-6.91M52.46%2.24M-35.51%-272.1M23.96%-62.07M62.36%-22.46M104.87%1.47M-41.94%-200.8M
Earning per share
Basic earning per share 2,750.00%0.11480.39%-0.10.00%-0.1275.00%-0.0133.33%0.004-37.84%-0.5120.00%-0.1263.64%-0.04105.36%0.003-42.31%-0.37
Diluted earning per share 2,750.00%0.11480.39%-0.10.00%-0.1275.00%-0.0133.33%0.004-37.84%-0.5120.00%-0.1263.64%-0.04105.36%0.003-42.31%-0.37
Other composite income -99.44K2,612.56%27.44M138.43%1.01M-124.40%-2.63M
Other composite income of parent company owners ---50.71K2,612.56%27.44M------------138.43%1.01M-------------124.40%-2.63M
Other composite income of minority owners ---48.72K------------------------------------
Total composite income 9,642.21%59.36M87.28%-35.53M2.20%-67.68M63.02%-9.99M182.35%609.29K-23.71%-279.44M25.51%-69.21M60.22%-27.02M97.80%-739.91K-47.27%-225.89M
Total composite income of parent company owners 2,631.13%61.14M89.82%-27.59M-1.09%-62.75M69.23%-6.91M52.46%2.24M-33.26%-271.09M23.96%-62.07M62.36%-22.46M104.87%1.47M-55.67%-203.43M
Total composite income of minority owners -9.61%-1.79M4.86%-7.94M30.83%-4.93M32.48%-3.08M26.21%-1.63M62.81%-8.35M36.72%-7.13M44.77%-4.56M35.88%-2.21M1.09%-22.46M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More